Metformin does not directly damage nerves, but it quietly lowers vitamin B12 levels over months and years of use, and that B12 depletion can cause or worsen a type of nerve damage that looks nearly identical to ordinary diabetic neuropathy. The connection runs through the gut, not the nerve itself, and the frustrating part is that the resulting neuropathy is often preventable and sometimes reversible if caught early. Yet many people on long-term metformin never have their B12 checked.
How Metformin Depletes Vitamin B12
Your body absorbs vitamin B12 through a multistep process that ends in the final stretch of the small intestine, the terminal ileum. There, a protein called intrinsic factor carries B12 to receptors on the intestinal wall, and the handoff depends on calcium. Metformin appears to interfere with that calcium-dependent step, effectively blocking the door through which B12 enters the bloodstream.1PubMed. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes Research has shown that supplemental calcium can reverse this malabsorption, which supports the idea that metformin’s interference centers on calcium availability at the gut lining rather than some broader metabolic disruption.2PubMed. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin
The effect is not dramatic day to day. B12 is stored in the liver, and most people carry enough reserves to last a few years. The problem is cumulative: metformin chips away at incoming B12 while the body slowly draws down its stores. By the time blood levels fall into the deficient range, the shortage may have been silently building for years.
How Common Is Metformin-Related B12 Deficiency
Multiple studies and meta-analyses confirm the association between long-term metformin use and low B12.3PubMed Central. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind The numbers vary depending on how deficiency is defined and how long people have been taking the drug, but a consistent pattern emerges across different populations.
In the Diabetes Prevention Program Outcomes Study, a large U.S. trial that followed participants for over a decade, those assigned to metformin were roughly twice as likely to have low or borderline-low B12 at the five-year mark compared to placebo. About one in five metformin users had low or borderline levels by that point. Each additional year of metformin use raised the odds of deficiency by about 13 percent.4PubMed Central. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study A large real-world database study found a similar trend, with each year of use increasing the odds of a deficiency lab result by about 5 percent, and long-term users showing a 41 percent greater likelihood of deficiency compared to short-term users.5Endocrine Practice. Effect of Metformin Use on Vitamin B12 Deficiency Over Time (EMBER): A Real-World Evidence Database Study
Metformin’s effect on B12 is not limited to people with type 2 diabetes. A systematic review found that the impact on B12 concentrations was nearly the same in patients with polycystic ovary syndrome (PCOS) as in those with diabetes, which makes sense given that the mechanism involves the gut, not blood sugar.6PLOS ONE. Vitamin B12 Status in Metformin Treated Patients: Systematic Review
Dose Matters More Than You Might Expect
When researchers tease apart which factors predict B12 deficiency in metformin users, daily dose consistently emerges as the strongest driver. In one study that categorized patients by their daily metformin intake, those taking 2,000 mg or more per day had roughly nine times the odds of B12 deficiency compared to those taking less than 1,000 mg per day. The 1,500 to 2,000 mg group had about three times the odds.7PubMed Central. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes Another study found that each additional gram of daily metformin nearly tripled the odds of deficiency and that using metformin for three or more years roughly doubled the risk compared to shorter durations.8JAMA Internal Medicine. Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin
The relationship between duration and deficiency is less straightforward. Some studies find a clear time-dependent risk, but others find that once you account for dose and other variables, the duration effect fades.9PubMed Central. Metformin-Associated Functional Vitamin B12 Deficiency Presenting as Subacute Combined Degeneration in a 57-Year-Old Man With Diabetes Mellitus In practical terms, if you are on a high dose of metformin, you do not necessarily need to wait years before B12 becomes a concern.
From Low B12 to Nerve Damage
Vitamin B12 is essential for maintaining the myelin sheath, the insulating layer around nerve fibers. When B12 runs low, myelin degrades and nerves begin to misfire or die. The resulting neuropathy typically starts in the feet and hands, causing numbness, tingling, burning pain, and sometimes balance problems. In more advanced cases it can progress to weakness and difficulty walking.
Here is why this matters so much for people with diabetes: the symptoms of B12-deficiency neuropathy overlap heavily with diabetic peripheral neuropathy, the nerve damage caused by chronically high blood sugar. Both produce similar patterns of numbness and pain in the extremities. Clinicians often attribute new tingling or pain in a diabetic patient’s feet to diabetes itself and never investigate B12.10PubMed. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy This diagnostic blind spot means treatable nerve damage gets written off as an inevitable complication of diabetes.
The clinical clues that point toward B12 deficiency rather than pure diabetic neuropathy include involvement of the upper limbs early on, loss of vibration sense and proprioception (the ability to sense where your limbs are in space), and certain patterns on nerve conduction studies that show both motor and sensory nerve involvement. One published case described a 57-year-old man on metformin for just one year who developed gait problems, diminished reflexes, and peripheral neuropathy involving both motor and sensory axons in his upper limb, along with gastrointestinal symptoms.9PubMed Central. Metformin-Associated Functional Vitamin B12 Deficiency Presenting as Subacute Combined Degeneration in a 57-Year-Old Man With Diabetes Mellitus His condition turned out to be subacute combined degeneration of the spinal cord, a serious but potentially reversible condition caused by B12 deficiency.
Prospective studies using nerve conduction testing have found measurable decreases in nerve conduction speed and signal amplitude in metformin users with low B12, confirming that the lab abnormality translates to real physiological nerve dysfunction.11Mymensingh Medical Journal. Serum Vitamin B12 Level in Patients with Type 2 Diabetes Mellitus on Metformin Therapy and its Impact on Peripheral Nerve Conduction: A Prospective Study The longer the deficiency persists, the less likely full recovery becomes, because nerve fibers eventually sustain irreversible damage.
It Is Not Just B12 on the Lab Report
Low B12 does not tell the whole story by itself. When B12 drops, the body accumulates two byproducts that are themselves toxic to nerves: homocysteine and methylmalonic acid (MMA). Both are markers of functional B12 deficiency, and elevated levels of either have been linked to worsening peripheral neuropathy in metformin users.12PubMed Central. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy A person’s total serum B12 can sometimes look borderline or even technically normal while MMA and homocysteine are already elevated, meaning nerve damage can begin before a standard blood test flags a problem. This is what clinicians call functional B12 deficiency, and it is part of why some patients develop neuropathy despite seemingly adequate B12 numbers.
Some observational data complicates this picture, though. One study of type 2 diabetes outpatients found that while metformin users did have significantly lower B12 levels, the prevalence of diabetic peripheral neuropathy was not statistically different between metformin users and non-users.13PubMed. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin This does not mean the B12-neuropathy link is imaginary, but it does suggest that diabetes-related nerve damage is so common and driven by so many factors (blood sugar control, duration of disease, lipid levels, genetics) that the B12 effect can be hard to isolate in cross-sectional snapshots. The patients who benefit most from B12 awareness are those in whom the deficiency is the primary or dominant cause of their symptoms, not just one contributor among many.
Who Faces the Highest Risk
Beyond dose and duration, genetics play a role. Researchers have identified a variant in the gene for cubilin, the protein that forms part of the receptor responsible for absorbing B12 in the gut. People who carry two copies of the risk variant (the AA genotype at rs1801222 in the CUBN gene) had a B12 deficiency rate of nearly 13 percent when using metformin, compared to about 6 percent in those with the common genotype. Without metformin exposure, the deficiency rate was only about 1 percent regardless of genotype, suggesting the genetic vulnerability specifically magnifies metformin’s effect.14PubMed. Identification of a genetic risk factor for metformin-induced vitamin B(12) deficiency This kind of pharmacogenetic interaction is not yet part of routine clinical practice, but it helps explain why some people on modest metformin doses develop severe B12 depletion while others on high doses never do.
Drug interactions also matter. Proton pump inhibitors (PPIs), commonly prescribed for acid reflux, independently reduce B12 absorption by lowering stomach acid, which is needed to release B12 from food. Combining a PPI with metformin compounds the risk. One study found that metformin plus a PPI raised the hazard of B12 deficiency by about 18 percent over metformin alone.15PubMed Central. Concomitant use of metformin and proton pump inhibitors increases vitamin B12 deficiency risk in type 2 diabetes A separate pharmacovigilance analysis flagged that the combination of metformin and pantoprazole specifically was associated with more serious outcomes, including hospitalizations.16PubMed Central. Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis If you take both a PPI and metformin, the case for monitoring B12 is even stronger.
Why B12 Monitoring Often Falls Through the Cracks
The American Diabetes Association updated its guidelines in 2017 to recommend periodic B12 monitoring for patients on metformin, particularly those who have been on it for four or more years or who have signs of neuropathy or anemia.17Diabetes. 131-LB: Prevalence of Vitamin B12–Monitoring among Patients Receiving Metformin in a Public Hospital In practice, compliance with this recommendation is patchy. Many health systems lack standardized screening protocols, and B12 testing is often not included in the routine lab panels ordered for diabetes management.18American Journal of Health-System Pharmacy. Vitamin B12 Monitoring in Metformin Users: Are We Missing an Opportunity for Safer Diabetes Care?
The gap between guideline and practice is particularly problematic because B12 deficiency can present without anemia. Many clinicians learned in training that B12 deficiency causes a specific type of large red blood cells (macrocytosis), and the absence of that finding on a routine blood count can falsely reassure them. But neurological damage from B12 deficiency can and does occur with normal-looking blood counts.10PubMed. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy Relying on anemia as a warning sign means you may catch the problem only after nerve damage is already well underway.
An Unexpected Twist: Metformin May Also Protect Nerves
This is where the story gets genuinely strange. While metformin’s B12-lowering effect can cause neuropathy, a growing body of preclinical research suggests metformin has direct neuroprotective properties through an entirely separate pathway. The drug activates an enzyme called AMPK, which plays a central role in cellular energy management and repair. Through AMPK, metformin appears to improve how neurons handle energy, promote nerve repair processes, and reduce the buildup of damaged proteins.19PubMed Central. Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system
In animal models, metformin has shown the ability to reverse neuropathic pain. One study in mice found that metformin reversed pain hypersensitivity caused by nerve injury, and the effect persisted for weeks after the drug was stopped.20PubMed Central. The antidiabetic drug metformin prevents and reverses neuropathic pain and spinal cord microglial activation in male but not female mice That study also revealed a sex difference: the protective effect appeared in male but not female mice, a finding that has not yet been fully explained. Other animal research has pointed to metformin’s ability to stimulate autophagy, the cellular cleanup process that removes damaged components, as a mechanism for relieving neuropathic pain after nerve injury.21PubMed Central. Metformin relieves neuropathic pain after spinal nerve ligation via autophagy flux stimulation
There is even early evidence that metformin may support the myelin-producing cells (Schwann cells) that wrap peripheral nerves. In a laboratory cell model, metformin treatment partially rescued Schwann cells from oxidative damage, helping to restore proteins associated with myelin production.22PubMed Central. Clemastine Restores Myelination Protein Expression in S16 Schwann Cells by Enhancing AMPK Activation and Reducing H(2)O(2)-Induced Oxidative Stress This is the same myelin that B12 deficiency destroys, so you have a drug that may be protecting nerve insulation through one mechanism while undermining it through another.
It is worth emphasizing that the neuroprotective findings are almost entirely from animal models and cell culture experiments. No large clinical trial has demonstrated that metformin prevents or treats neuropathy in humans. But the research does suggest that simply labeling metformin as “bad for nerves” misses the complexity. The net effect on any individual’s nervous system likely depends on whether their B12 status is maintained.
Prevention and Treatment
The most direct preventive measure is B12 supplementation. Oral B12 supplements are widely available over the counter, and a comparison of oral versus intramuscular B12 in metformin-treated patients with documented deficiency found that oral supplementation was as effective as injections at restoring B12 levels over six months.23Journal of the Endocrine Society. MON-520 Comparison of Oral and Intramuscular Vitamin B12 Supplementation in Metformin-Treated Diabetes Mellitus Patients With Vitamin B12 Deficiency This is reassuring because it means most people do not need regular clinic visits for injections. One trial found that daily oral cyanocobalamin at 1,000 micrograms for eight weeks brought B12 levels well into the normal range and improved neurological symptoms, though a less intensive weekly schedule raised levels more modestly.24Russian Journal of Preventive Medicine. Possibilities of oral form of cyanocobalamin in pharmacological correction of vitamin B12 deficiency developed in patients with type 2 diabetes mellitus during treatment with metformin
Calcium supplementation offers a second angle of protection. Because metformin’s B12-blocking mechanism centers on calcium-dependent absorption, taking calcium alongside metformin can help restore B12 uptake. A pilot study using a radioactive B12 tracer in healthy adults confirmed that co-administering calcium with metformin reversed the drug’s inhibition of B12 absorption.25Clinical Nutrition ESPEN. Effect of calcium supplementation on reversing metformin-based inhibition of vitamin B12 bioavailability in healthy adults using a [13C] cyanocobalamin tracer – A pilot study This does not mean calcium alone is sufficient to prevent deficiency, especially in someone already depleted, but it represents a simple, low-risk strategy to slow the drain.
If you are already experiencing neuropathy symptoms and take metformin, the most useful step is to ask for a B12 level, along with MMA and homocysteine if the B12 result is borderline. Catching functional deficiency before it progresses to severe nerve damage is the window where treatment makes the biggest difference. Nerve damage that has persisted for years may not fully reverse even after B12 is corrected, though some improvement in symptoms is still possible.
Folate and the Masking Problem
Metformin’s micronutrient effects may extend beyond B12 alone. Some observational data suggests that long-term use can also lower folate levels, another B vitamin critical for nerve health and DNA synthesis.26Medical Hypotheses. Adverse effect of metformin therapy on serum vitamin B12 and folate: Short-term treatment causes disadvantages? Folate is worth mentioning here for a specific reason: in countries where flour and grain are fortified with folic acid (including the United States), people often maintain adequate folate levels even when their B12 is crashing. High folate can mask the blood-cell changes that would otherwise tip off a doctor to B12 deficiency, because folate partially compensates for B12’s role in red blood cell production. The anemia gets masked, but the neurological damage continues unchecked. This masking effect makes direct B12 testing, rather than relying on routine blood count abnormalities, all the more important for anyone on metformin.